Monthly Archives: October 2019

October 30, 2019

Curasight receives EPO patent notification with issue date 28 August 2019 and patent number 2928505 Curasight have provided a positron-emitting radionuclide labelled peptide (uTRACEĀ®) for non-invasive PET imaging of the Urokinase-type Plasminogen Activator Receptor (uPAR) in humans. Curasight has developed a novel radiopharmaceutical platform (uTRACEĀ®) for improved diagnose, risk stratification and treatment monitoring for cancer […]